Improved Therapeutic Efficacy of MT102, a New Anti-Inflammatory Agent, via a Self-Microemulsifying Drug Delivery System, in Ulcerative Colitis Mice

Improved Therapeutic Efficacy of MT102, a New Anti-Inflammatory Agent, via a Self-Microemulsifying Drug Delivery System, in Ulcerative Colitis Mice

MT-102 is a new anti-inflammatory agent derived from <i>Juglans mandshurica</i> and <i>Isatis indigotica</i>. Its therapeutic potential is hindered by low aqueous solubility, impacting its in vivo efficacy. Therefore, this study aimed to develop a self-microemulsifying drug d...

Full description

Bibliographic Details
Main Authors: Kshitis Chandra Baral, Sang Hoon Lee, Jae Geun Song, Seong Hoon Jeong, Hyo-Kyung Han
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Pharmaceutics
Subjects:
solubility
inflammation
self-microemulsifying drug delivery system
oral efficacy
Online Access:https://www.mdpi.com/1999-4923/15/12/2720

Internet

https://www.mdpi.com/1999-4923/15/12/2720

Similar Items